The Pancreatic Cancer Action Network and the American Association for Cancer Research (AACR) awarded a $200,000 grant today to Dr. Michael Barrett of the Translational Genomics Research Institute (TGen). Dr.…
The strategic plan that has guided Arizona’s fast-growing bioscience sector for nearly 12 years is gearing up for a new decade. “Arizona’s Bioscience Roadmap: 2014-2025” will be unveiled starting April…
Phoenix Mayor Greg Stanton and the City Council today approved the Phoenix Industrial Development Authority to issue up to $180 million in revenue bonds to finance Mayo Clinic’s new proton…
Banner Alzheimer’s Foundation, the philanthropic resource for Phoenix-based Banner Alzheimer’s Institute (BAI), part of the nonprofit Banner Health, received $2 million in grant funding from the Flinn Foundation, a privately…
Abrazo Health announced that Phoenix Baptist Hospital is now home to a new state-of-the-art Neuroscience expansion. The new suite will include all the latest equipment, including a Biplane Neuroangiography System.…
The Greater Phoenix Chamber of Commerce has selected the Translational Genomics Research Institute (TGen) for one of its 2014 Impact Awards. TGen was selected among small to medium business in…
University of Arizona researchers have been awarded a $200,000 two-year seed grant by the Flinn Foundation through its Promoting Translational Research in Precision Medicine grants program to define the pulmonary…
A short-term study led by C. Kent Kwoh, MD, director of the University of Arizona Arthritis Center, and a collaborative team of researchers has found that oral glucosamine supplementation is…
Under a new grant from the National Institutes of Health (NIH), Phoenix Children’s Hospital, Barrow Neurological Institute and the Translational Genomics Research Institute (TGen) are studying the role of extracellular…
In association with its 50th anniversary, the American Society of Clinical Oncology (ASCO) has named Daniel D. Von Hoff, M.D., FACP, one of ASCO’s 50 Oncology Luminaries, celebrating 50 doctors…
Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and…
Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug…
